Approval · Notice of Compliance 13778 · 2012
ESBRIET: Notice of Compliance 13778
Issued October 29, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13778
- Date
- October 29, 2012
- Company
- Intermune Canada Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-fibrotic; anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESBRIET | 02393751 | Cancelled Post Market |
Medicinal ingredients
- PIRFENIDONE 267 MG per CAP